2015 AACC

A Survey of Personalized Medicine: The PGx, PK and PD Of It All-35204 (Room Georgia World Congress Center - B312)

30 Jul 15
11:30 AM - 2:00 PM

Tracks: Biomarkers, Cancer, Mass Spectrometry, Metabolites, Personalized Medicine, Pharmacogenomics, Proteomics, TDM, Testing Methods

Speaker(s): William Clarke, PhD,MBA, DABCC, FAACC, Professor of Pathology, Director of Pointof-Care Testing and Clinical Toxicology, John Hopkins University School of Medicine; Gwendolyn McMillin, University of Utah / ARUP Laboratories; Mark Marzinke, John Hopkins Hospital

After this session, participants will be able to: 1) Discuss the interplay between PGx, PK and PD as it relates to optimal therapeutic treatment regimens; 2) Identify traditional and newer drugs used for the treatment of cancer, epilepsy, mood disorders, and related indications such as depression and neuropathic pain; and 3) Describe how pharmacotherapies may be impacted in various clinical settings